Tech Company Financing Transactions

DNAtriX Funding Round

DNAtriX secured a $885.6 thousand funding round on 8/6/2012. Backers included private investors.

Transaction Overview

Company Name
Announced On
8/6/2012
Transaction Type
Venture Equity
Amount
$885,620
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2450 Holcombe Blvd. X 200
Houston, TX 77021
USA
Email Address
Overview
DNAtrix is a clinical stage, biotechnology company developing virus-driven immunotherapies for cancer. DNAtrix s lead product, DNX-2401, is a modified common cold virus that targets and kills cancer cells selectively.
Profile
DNAtriX LinkedIn Company Profile
Social Media
DNAtriX Company Twitter Account
Company News
DNAtriX News
Facebook
DNAtriX on Facebook
YouTube
DNAtriX on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Frank Tufaro
  Frank Tufaro LinkedIn Profile  Frank Tufaro Twitter Account  Frank Tufaro News  Frank Tufaro on Facebook
Chief Financial Officer
Brian Mooney
  Brian Mooney LinkedIn Profile  Brian Mooney Twitter Account  Brian Mooney News  Brian Mooney on Facebook
VP - Bus. Development
Brett Ewald
  Brett Ewald LinkedIn Profile  Brett Ewald Twitter Account  Brett Ewald News  Brett Ewald on Facebook
VP - Manufacturing
Erin Mitchell
  Erin Mitchell LinkedIn Profile  Erin Mitchell Twitter Account  Erin Mitchell News  Erin Mitchell on Facebook
VP - R & D
Karen Gammon
  Karen Gammon LinkedIn Profile  Karen Gammon Twitter Account  Karen Gammon News  Karen Gammon on Facebook
VP - R & D
Imre Kovesdi
  Imre Kovesdi LinkedIn Profile  Imre Kovesdi Twitter Account  Imre Kovesdi News  Imre Kovesdi on Facebook
VP - R & D
Joan Robbins
  Joan Robbins LinkedIn Profile  Joan Robbins Twitter Account  Joan Robbins News  Joan Robbins on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/6/2012: RedPath Integrated Pathology venture capital transaction
Next: 8/6/2012: Millendo Therapeutics venture capital transaction

 

Share this article

 


About Database of VC Transactions

Our team works diligently to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary